Organic compounds -- part of the class 532-570 series – Organic compounds – Radioactive metal containing
Patent
1995-02-22
1997-11-04
Wu, Shean C.
Organic compounds -- part of the class 532-570 series
Organic compounds
Radioactive metal containing
534 14, 5483037, 300367, 300404, 424 157, 424 165, 424 153, C07F 1300, C07D47300, C07K 1477
Patent
active
056841370
ABSTRACT:
Novel chelating compounds and the corresponding radionuclide metal chelates are useful for radiolabeling proteins such as antibodies, ligands such as biotin and anti-ligands such as streptavidin with radionuclide metals such as .sup.99m Tc, .sup.186 Re, and .sup.188 Re. The radiolabeled proteins, ligands and anti-ligands have diagnostic or therapeutic use, depending on the radionuclide metal chosen.
REFERENCES:
patent: 2810753 (1957-10-01), Bersworth
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4775745 (1988-10-01), Ford et al.
patent: 4789736 (1988-12-01), Canning et al.
patent: 4833251 (1989-05-01), Musso et al.
patent: 4849511 (1989-07-01), Verbruggen
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 4883862 (1989-11-01), Chervu et al.
patent: 4895955 (1990-01-01), Ford et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4898951 (1990-02-01), Symons
patent: 4963682 (1990-10-01), Bodor
patent: 4963688 (1990-10-01), Bodor
patent: 4965392 (1990-10-01), Fritzberg et al.
patent: 4988496 (1991-01-01), Srinivasan et al.
patent: 5256395 (1993-10-01), Barbet et al.
patent: 5283342 (1994-02-01), Gustavson et al.
Lever et al., Tetrahedron Letters, vol. 29, No. 26, pp. 3219-3222, 1988 (Printed in Great Britain), "Synthesis of a novel bifunctional chelate designed for labeling proteins with technetium-99m".
Mastrostamatis et al., Eur. J. Nucl. Med., Suppl. to vol. 16, 1990, Abstract No. 428, "Tripodal N,S.sub.3 -donor ligands as a new backbone for reduced technetium".
Corbin et al., Inorganica Chimica Acta, 90 (1984), pp. 41-51, "Preparation and properties of tripodal and linear tetradentate N,S-donor ligands and their complexes containing the MoO.sub.2.sup.2+ core". Biochem. J., vol. 89, p. 585, 1963.
Kalofonos et al., "Imaging of Tumor in Patients with Indium-111-Labeled Biotin and Streptavidin-Conjugated Antibodies: Preliminary Communication," J. Nucl. Med., vol. 31, No. 11, pp. 1791-1796, 1990.
Hnatowich et al., "Investigations of Avidin and Biotin for Imaging Applications," J. Nucl. Med., vol. 28, No. 8, pp. 1294-1302, 1987.
Paganelli et al., "Intraperitoneal Radio-Localization of Tumors Pre-targeted by Biotinylated Monoclonal Antibodies," Int. J. Cancer, vol. 45, pp. 1184-1189, 1990.
Paganelli et al., "Monoclonal antibody pretargeting techniques for tumour localization: the avidin-biotin system," Nucl. Med. Communications, vol. 12, pp. 211-234, 1991.
Goodwin/Hnatowich, Letter to the Editor/Reply, J. Nucl. Med., vol. 32, No. 4 pp. 750-751, 1991.
Rosebrough, Abstract No. 235, J. Nucl. Med., p. 880, 1992, "Plasma stability and Pharmacokinetics of Radio-labeled Deferozamine-Biotin Derivatives."
Virzi et al., Abstract No. 403, J. Nucl. Med., p. 920, 1992, "The preparation and Evaluation of 12 Biotin Derivatives labeled with Tc-99m."
Rosario et al., Abstract No. 356, J. Nucl. Med., vol. 32, No. 5, p. 993, 1991, "Bolton-Hunter and Biotin derivatized polylysine: A new multi-valent peptide reagent for in vivo pre-targeting with streptavidin conjugates."
Gustavson Linda M.
Kasina Sudhakar
Chapman Lara E.
NeoRx Corporation
Wu Shean C.
LandOfFree
S.sub.3 N chelating compounds for the radiolabeling of ligands, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with S.sub.3 N chelating compounds for the radiolabeling of ligands, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and S.sub.3 N chelating compounds for the radiolabeling of ligands, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1834066